DIABPCO: Chronic Obstructive Pulmonary Disease (COPD) and Advance Directives

Sponsor

Centre Hospitalier René Dubos (Other)

Overall Status

Completed

CT.gov ID

NCT04459143

Collaborator

(none)

525

Enrollment

Location

17.5

Actual Duration (Months)

29.9

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate if the participation of COPD patients to a workshop on advance directives increases the number of patients who write them.

Condition or Disease	Intervention/Treatment	Phase
Chronic Obstructive Pulmonary Disease	Behavioral: Advance directives

Detailed Description

Chronic Obstructive Disease is a common disease and should be the third leading cause of death in 2020. Patient hospitalized for an exacerbation of their COPD have a median survival of 2 years and 50% risk of being rehospitalized within 6 months.

COPD patients may have symptoms that impair their life quality significantly and sometimes more than patients with cancer. This is particularly the case for dyspnea, which is frequently present.

In the study, Investigators propose the setting up of health workshop on advance directives. This workshop is for sever or very severe COPD patients during their hospital stay in the post-acute care and pulmonary rehabilitation service.

In this unit, investigators welcome patient from all the region of Ile de France for a hospital stay of approximately 6 weeks. A first workshop will take place during the third week of their care to inform them about COPD, exacerbations, prognostic and advance directives. Then, a personal interview with patients who have participated to this workshop will take place to collect their advance directives and their degree of satisfaction about this process.

Study Design

Study Type:

Observational

Actual Enrollment :

525 participants

Observational Model:

Cohort

Time Perspective:

Prospective

Official Title:

Chronic Obstructive Pulmonary Disease (COPD) and Advance Directives

Actual Study Start Date :

May 16, 2019

Actual Primary Completion Date :

Oct 31, 2020

Actual Study Completion Date :

Oct 31, 2020

Outcome Measures

Primary Outcome Measures

Number of patient who write their advance directives [At the end of patient hospital stay, approximately 6 weeks]
The Primary Outcome Measure is the collect of the number of patients who write their advance directives after their participation of the health workshop

Secondary Outcome Measures

Measure of patient's satisfaction [At the end of patient hospital stay, approximately 6 weeks]
The satisfaction of patient was measured with a satisfaction questionnaire scale based on their feelings about the workshop. For each item, patient ticks : Strongly agree, Agree, Neither agree or disagree, Disagree or Strongly disagree

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

COPD Gold 3 or 4 and Curtis criteria

Exclusion Criteria:

left to the discretion of the investigator if he finds that it will not be beneficial for the patient : for example if the workshop is judged to be at risk of being anxiety-provoking